Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
ACI Clinical (www.aciclinical.com), a specialty group in clinical research that manages Endpoint Adjudication Committees and Data Monitoring Committees, announced a new, standards-based platform for independent Data Monitoring Committees.
ACI analyzed its DMC member data request trends to create an automated design of standard statistical output, presented in a clinically meaningful format. This understanding of Data Monitoring Committees has allowed ACI to offer new efficiencies while maintaining regulatory-grade quality and features such as double programming. ACI debuted its DMC process was to CDISC members in Europe early this year, in an effort to demonstrate how standardized statistical output may be a highly useful training tool for DMC members.
Industry pricing for DMCs varies based on factors including study size, duration and volume of analysis datasets, tables, figures and listings.
Read the full release here.